Onychomycosis therapies: strategies to improve efficacy.
The combination of relatively high treatment failure rates and infection relapse rates warrants consideration of ways in which antifungal therapy can be delivered so that efficacy rates can be improved. These involve the combination of available therapies and/or a modification of treatment regimens.
Gupta
Aditya K
AK
Division of Dermatology, Department of Medicine, Sunnybrook and Women's College Health Sciences Centre, (Sunnybrook Site), University of Toronto, 2075 Bayview Avenue, Toronto, ON M4N 3M5, Canada. agupta@execulink.com
Tu
Linh Q
LQ
D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005533:Foot Dermatoses / Q000473:pathology / Q000628:therapy; D006229:Hand Dermatoses / Q000473:pathology / Q000628:therapy; D006801:Humans; D014009:Onychomycosis / Q000473:pathology / Q000628:therapy*
D000935:Antifungal Agents